The combination of a novel glut1 inhibitor and cisplatin synergistically inhibits breast cancer cell growth by enhancing the dna damaging effect and modulating the akt/mtor and mapk signaling pathways

HIGHLIGHTS

• who: Inhibitor and collaborators from the School of Pharmacy, National Taiwan University, Taipei, Taiwan, Department of Pharmacy, Taipei Municipal TuCheng have published the research work: The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways, in the Journal: (JOURNAL)
• what: The authors report that #43 enhances the cytotoxic effect of cisplatin against breast cancer cells by augmenting its DNA damaging effect. 2-NBDG uptake assay followed by flow cytometric analysis was conducted to determine the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.